$1.84
-0.01-0.54%
Pre-Market: 4:01 AM EDT
Comments
Loading...
BioCardia (BCDA) Forecast
NewsEarningsBioCardia (BCDA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBioCardia (NASDAQ:BCDA) Stock Quotes, Forecast and News Summary
BioCardia Stock (NASDAQ: BCDA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioCardia (BCDA) stock?
You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.
Who are BioCardia (BCDA) competitors?
Other companies in BioCardia’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Evaxion Biotech (NASDAQ:EVAX) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for BioCardia (BCDA) stock?
BioCardia has a consensus price target of $25.00.
What is the current price for BioCardia (BCDA)?
The stock price for BioCardia (NASDAQ: BCDA) is $1.84 last updated November 18, 2024 at 4:01 AM EST.
Does BioCardia (BCDA) pay a dividend?
There are no upcoming dividends for BioCardia.
When is BioCardia (NASDAQ:BCDA) reporting earnings?
BioCardia’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is BioCardia (BCDA) going to split?
There is no upcoming split for BioCardia.
What sector and industry does BioCardia (BCDA) operate in?
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.